{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:36:43Z","timestamp":1773387403978,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clml.2015.02.015","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T12:13:33Z","timestamp":1439900013000},"page":"S158-S160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Ocular Adnexal Lymphomas: Single-Center Experience"],"prefix":"10.1016","volume":"15","author":[{"given":"Melda C\u00f6mert","family":"\u00d6zkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melis","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Tombulo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Hekimgil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazan","family":"\u00d6zsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2015.02.015_bib1","first-page":"581856","article-title":"Mantle cell lymphoma and involvement of the orbit and ocular adnexa","volume":"2013","author":"Khojeini","year":"2013","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.clml.2015.02.015_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-8140(88)90218-6","article-title":"Orbital and conjunctival lymphoma: treatment and prognosis","volume":"13","author":"Bessel","year":"1988","journal-title":"Radither Oncol"},{"key":"10.1016\/j.clml.2015.02.015_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa\u2013associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2015.02.015_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0161-6420(98)98024-1","article-title":"Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases","volume":"105","author":"Coupland","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clml.2015.02.015_bib5","first-page":"328","article-title":"Outcome and prognostic factors in ocular adnexal lymphoma","volume":"45","author":"Nola","year":"2004","journal-title":"Croat Med J"},{"key":"10.1016\/j.clml.2015.02.015_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-Hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2015.02.015_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","article-title":"Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2015.02.015_bib8","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.015_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2015.02.015_bib10","first-page":"209","article-title":"Ocular adnexal MALTomas: case series\u00a0of patients treated with primary radiation","volume":"11","author":"Russell","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.clml.2015.02.015_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.741","article-title":"Ophthalmologic and intraocular non-Hodgkin\u2019s lymphoma: a large single centre study of initial characteristics, natural history and prognostic factors","volume":"22","author":"Meunier","year":"2004","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2015.02.015_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/IOP.0b013e3182916495","article-title":"Ocular adnexal lymphoma: monitoring response to therapy with diffusion-weighted imaging","volume":"29","author":"Prat","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2015.02.015_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1179\/102453312X13221316477813","article-title":"Value of (18)FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience","volume":"17","author":"Zanni","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2015.02.015_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular\u00a0dnexa: a multiinstitutional, retrospective review of 50 patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2015.02.015_bib15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijrobp.2011.12.097","article-title":"Risk of radiation retinopathy in patients\u00a0with orbital and ocular lymphoma","volume":"84","author":"Kaushik","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2015.02.015_bib16","first-page":"1393","article-title":"Ophthalmologic outcomes after chemotherapy and\/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma","volume":"91","author":"Paik","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2015.02.015_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(02)00337-5","article-title":"Ocular adnexal lymphomas: five case presentations and a review of the literature","volume":"47","author":"Coupland","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clml.2015.02.015_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5301\/ejo.5000224","article-title":"Ocular adnexal lymphoma staging and\u00a0treatment: American Joint Committee on Cancer versus Ann Arbor","volume":"23","author":"Graue","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clml.2015.02.015_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2147\/OPTH.S5828","article-title":"Treatment options for ocular adnexal lymphoma (OAL)","volume":"3","author":"Cohen","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clml.2015.02.015_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.leukres.2011.01.030","article-title":"Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation","volume":"35","author":"Laurenti","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2015.02.015_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00432-013-1438-9","article-title":"Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections","volume":"139","author":"Savino","year":"2013","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clml.2015.02.015_bib22","first-page":"1","article-title":"Systemic rituximab immunotherapy in\u00a0the management of primary ocular adnexal lymphoma: single institution experience","volume":"23","author":"Tuncer","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clml.2015.02.015_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1076\/orbi.21.2.117.7192","article-title":"Results of radiotherapy for orbital and adnexal lymphoma","volume":"21","author":"Liao","year":"2002","journal-title":"Orbit"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265015000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265015000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T01:52:21Z","timestamp":1537408341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265015000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":23,"alternative-id":["S2152265015000440"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2015.02.015","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Adnexal Lymphomas: Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2015.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}